Vaccine Innovation & Immunotherapeutics
We are advancing next-generation vaccines and immune-based therapies that are safer, more precise, and more effective.
Our faculty design novel antigen delivery systems, engineer adjuvants, and define immune mechanisms that drive durable protection against infectious diseases, cancer, and immune-mediated disorders.
Faculty in this area include:
- Dr. Abdelwahab – Nanoparticle and bioconjugation vaccine platforms
- Dr. DeBuysscher – B cell immunity and vaccine responses
- Dr. Evans – Translational vaccine and immunotherapy development
- Dr. Riel – Rational design of immunomodulatory adjuvants
- Dr. Shepherd – Environmental impacts on immune function and therapeutic modulation